|
Index of reports
> Cases resulting in life threatening events (33)
> Cases with Hyperkalaemia (9)
Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in life threatening events where reactions include hyperkalaemia.
Adverse event in female receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-10-24
Patient: female, weighing 46.5 kg (102.3 pounds)
Adverse reactions / side effects: Sick Sinus Syndrome, Hyperkalaemia
Adverse event resulted in: life threatening event
Suspect drug(s):
Enalapril Maleate
Administration route: Oral
Indication: Hypertension
Start date: 2006-04-26
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2003-01-14
End date: 2007-08-19
Spironolactone
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2007-08-01
End date: 2007-08-19
Vesicare
Administration route: Oral
Indication: Hypertonic Bladder
Start date: 2007-02-21
End date: 2007-08-19
Other drugs received by patient: Herpamine (Denopamine); Diart; Promac (Polaprezinc); Goodmin; Minzain
Adverse event in female receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-07-24
Patient: female, weighing 61.5 kg (135.3 pounds)
Adverse reactions / side effects: Hyperkalaemia, Bradyarrhythmia, Hypotension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-02-01
End date: 2007-06-27
Micardis
Indication: Hypertension
Start date: 2005-01-01
End date: 2007-06-27
Other drugs received by patient: Amaryl; Basen; Aspirin; Lasix; Artist; Frandol; Magnesium Oxide
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-23
Patient: male, weighing 53.8 kg (118.4 pounds)
Adverse reactions / side effects: Renal Failure, Hyperkalaemia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Norvasc; Diltiazem HCL; Aspirin; Omepral; Sigmart; Ticlopidine HCL
Adverse event in female receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-23
Patient: female, weighing 51.5 kg (113.3 pounds)
Adverse reactions / side effects: Hyperkalaemia, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Diart; Aspirin; Lipitor; Zantac
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-12
Patient: male, weighing 53.8 kg (118.4 pounds)
Adverse reactions / side effects: Renal Failure, Hyperkalaemia, Blood Creatinine Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Norvasc; Diltiazem HCL; Aspirin; Omepral; Sigmart; Ticlopidine HCL
Adverse event in female receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-08
Patient: female, weighing 51.5 kg (113.3 pounds)
Adverse reactions / side effects: Hyperkalaemia, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Diart; Aspirin; Lipitor; Zantac
Adverse event in male receiving Micardis (Telmisartan)
Reported by a physician from Japan on 2007-03-08
Patient: male, weighing 53.8 kg (118.4 pounds)
Adverse reactions / side effects: Renal Failure, Hyperkalaemia, Blood Creatinine Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Micardis (Telmisartan)
Other drugs received by patient: Norvasc; Diltiazem HCL; Aspirin; Omepral; Sigmart; Ticlopidine HCL
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Sweden on 2007-02-16
Patient: female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Hyperkalaemia, Atrioventricular Block Complete, Atrial Fibrillation, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Carvedilol
Micardis
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2003-03-26
Micardis
Indication: Cerebrovascular Accident Prophylaxis
Ramipril
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2003-03-26
Ramipril
Indication: Cerebrovascular Accident Prophylaxis
Adverse event in female receiving Micardis (Telmisartan)
Reported by a individual with unspecified qualification from Sweden on 2007-01-30
Patient: female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Hyperkalaemia, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Carvedilol
Micardis
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2003-03-26
Micardis
Indication: Cerebrovascular Accident Prophylaxis
Ramipril
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2003-03-26
Ramipril
Indication: Cerebrovascular Accident Prophylaxis
|
